ATP2A2 and cardiomyopathy: ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2) was identified as a target of miRNA-323-3p, which could be involved in and have an impact on cardiomyopathy progression [30].